Ustekinumab for the Treatment of Refractory Crohnʼs Disease: The Spanish Experience in a Large Multicentre Open-label Cohort - Khorrami, S; Ginard, D; Marin-Jimenez, I (Inflamm Bowel Dis, 2016)
et al.